Advances in the biosynthesis of β-carotene and its derivatives in yeast
- PMID: 40614874
- DOI: 10.1016/j.biortech.2025.132936
Advances in the biosynthesis of β-carotene and its derivatives in yeast
Abstract
β-Carotene and its derivatives have been gaining huge interest due to its applications as food supplements, nutraceuticals, pharmaceuticals, pigments, etc. Owing to their high values, sustainable microbial production has been a heated research topic. Traditional production methods, such as plant extraction and chemical synthesis, face challenges in scalability, cost, and environmental impact. With advances in synthetic biology, yeast-based biosynthesis has emerged as a promising alternative. This review provides a comprehensive summary of recent progress in the metabolic engineering strategies and fermentation optimization approaches of yeast, particularly Saccharomyces cerevisiae and Yarrowia lipolytica, for the production of β-carotene and its derivatives. In contrast to previous reviews, this work emphasizes the shared biosynthetic logic underlying structurally related derivatives, classifying them into two major groups: xanthophylls (canthaxanthin, zeaxanthin, astaxanthin, and violaxanthin) and apocarotenoids (crocetin, retinol, β-ionone, β-cyclocitral, and strigolactones). Representative cases and transferable engineering/fermentation strategies are highlighted. Advantages and limitations of yeast species as production hosts are thoroughly compared, and potential strategies to improve the production are discussed. Future work may focus on broadening product diversity in different yeast hosts and enhancing biosynthetic efficiency for a more sustainable production.
Keywords: Apocarotenoid; Bioproduction; Carotenoid; Fermentation; Metabolic engineering; Xanthophylls; Yeast; β-Carotene.
Copyright © 2025 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Metabolic engineering of Saccharomyces cerevisiae for neoxanthin production.Microb Cell Fact. 2025 Aug 1;24(1):176. doi: 10.1186/s12934-025-02789-8. Microb Cell Fact. 2025. PMID: 40751238 Free PMC article.
-
Unlocking the Potential of Medicago truncatula A17 Cell Suspension Cultures for Bioproduction of Astaxanthin and Canthaxanthin.Biotechnol Bioeng. 2025 Aug;122(8):2228-2240. doi: 10.1002/bit.29009. Epub 2025 May 2. Biotechnol Bioeng. 2025. PMID: 40317979
-
A Comprehensive Review of l-Theanine Production in Escherichia coli: The Recent Progress, Metabolic Engineering Strategies, and Future Prospects.ACS Synth Biol. 2025 Jul 18;14(7):2433-2444. doi: 10.1021/acssynbio.5c00291. Epub 2025 Jul 4. ACS Synth Biol. 2025. PMID: 40613122 Review.
-
Oilseed-based metabolic engineering of astaxanthin and related ketocarotenoids using a plant-derived pathway: Lab-to-field-to-application.Plant Biotechnol J. 2025 Aug;23(8):3451-3464. doi: 10.1111/pbi.70148. Epub 2025 Jun 3. Plant Biotechnol J. 2025. PMID: 40457958 Free PMC article.
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources